ZYUS Life Sciences Corporation
Financial Statements (IFRS) · Amounts in CAD
Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 105,000 | 120,000 | 114,000 | 126,000 | 123,000 | -- |
| Operating Revenue | 105,000 | 120,000 | 114,000 | 126,000 | 123,000 | -- |
| Cost Of Revenue | 109,000 | 51,000 | 54,000 | 190,000 | 52,000 | -- |
| Gross Profit | -4,000 | 69,000 | 60,000 | -64,000 | 71,000 | -- |
| Selling General And Administration | 2.0M | 2.4M | 2.1M | 1.8M | 2.2M | -- |
| General And Administrative Expense | 2.0M | 2.4M | 2.1M | 1.7M | 2.1M | -- |
| Research And Development | 257,000 | 865,000 | 551,000 | 371,000 | 808,000 | -- |
| Depreciation And Amortization In Income Statement | 723,000 | 676,000 | 694,000 | 792,000 | 721,000 | -- |
| Other Operating Expenses | 6,000 | 61,000 | 135,000 | 193,000 | 36,000 | -- |
| Operating Expense | 3.0M | 4.0M | 3.5M | 3.1M | 3.7M | -- |
| Operating Income | -3.0M | -4.0M | -3.4M | -3.2M | -3.7M | -- |
| EBIT | -3.1M | -4.0M | -3.5M | -23.6M | -3.7M | -- |
| Interest Expense | 487,000 | 432,000 | 432,000 | 199,000 | 190,000 | -- |
| Interest Expense Non Operating | 487,000 | 432,000 | 432,000 | 199,000 | 190,000 | -- |
| Net Interest Income | -633,000 | -508,000 | -516,000 | -282,000 | -328,000 | -- |
| Other Income Expense | 35,000 | 50,000 | -7,000 | -20.3M | 53,000 | -- |
| Gain On Sale Of Security | 35,000 | 50,000 | -7,000 | 3,000 | 53,000 | -- |
| Pretax Income | -3.6M | -4.4M | -4.0M | -23.8M | -3.9M | -- |
| Tax Provision | 0.00 | 0.00 | 0.00 | -2.0M | -17,000 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | -1.7M | 228.97 | -- |
| Net Income From Continuing And Discontinued Operation | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Income From Continuing Operation Net Minority Interest | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Income Including Noncontrolling Interests | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Income Common Stockholders | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Income | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| EBITDA | -2.4M | -3.3M | -2.8M | -22.8M | -3.0M | -- |
| Normalized EBITDA | -2.4M | -3.4M | -2.8M | -2.5M | -3.1M | -- |
| Reconciled Depreciation | 723,000 | 676,000 | 694,000 | 792,000 | 721,000 | -- |
| Basic EPS | -0.05 | -0.06 | -0.05 | -- | -0.05 | -0.07 |
| Diluted EPS | -0.05 | -0.06 | -0.05 | -- | -0.05 | -0.07 |
| Basic Average Shares | 77.9M | 75.6M | 74.4M | -- | 72.2M | 70.8M |
| Diluted Average Shares | 77.9M | 75.6M | 74.4M | -- | 72.2M | 70.8M |
| Total Unusual Items | 35,000 | 50,000 | -7,000 | -20.3M | 53,000 | -- |
| Total Unusual Items Excluding Goodwill | 35,000 | 50,000 | -7,000 | -20.3M | 53,000 | -- |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | -- |
| Normalized Income | -3.7M | -4.5M | -4.0M | -3.2M | -4.0M | -- |
| Depreciation Amortization Depletion Income Statement | 723,000 | 676,000 | 694,000 | 792,000 | 721,000 | -- |
| Diluted NI Availto Com Stockholders | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Income Continuous Operations | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Non Operating Interest Income Expense | -633,000 | -508,000 | -516,000 | -282,000 | -328,000 | -- |
| Other Gand A | 2.0M | 2.3M | 2.0M | -3.0M | 2.0M | -- |
| Reconciled Cost Of Revenue | 109,000 | 51,000 | 54,000 | 190,000 | 52,000 | -- |
| Salaries And Wages | 35,000 | 47,000 | 50,000 | 4.8M | 99,000 | -- |
| Selling And Marketing Expense | 45,000 | 47,000 | 46,000 | 53,000 | 61,000 | -- |
| Total Expenses | 3.1M | 4.1M | 3.5M | 3.3M | 3.8M | -- |
| Total Operating Income As Reported | -3.0M | -4.0M | -3.4M | -23.5M | -3.7M | -- |
| Total Other Finance Cost | 146,000 | 76,000 | 84,000 | 83,000 | 138,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 361,000 | 559,000 | 663,000 | 1.9M | 346,000 | -- |
| Cash Cash Equivalents And Short Term Investments | 361,000 | 559,000 | 663,000 | 1.9M | 346,000 | -- |
| Cash Financial | 361,000 | 559,000 | 663,000 | 1.9M | 346,000 | -- |
| Other Short Term Investments | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Accounts Receivable | 392,000 | 339,000 | 314,000 | 52,000 | 405,000 | -- |
| Receivables | 392,000 | 339,000 | 314,000 | 366,000 | 405,000 | -- |
| Inventory | 458,000 | 541,000 | 573,000 | 630,000 | 2.0M | -- |
| Prepaid Assets | -- | -- | -- | 275,000 | -- | -- |
| Other Current Assets | 386,000 | 362,000 | 348,000 | 189,000 | 772,000 | -- |
| Current Assets | 1.6M | 1.8M | 1.9M | 3.4M | 3.5M | -- |
| Gross PPE | 9.1M | 9.8M | 10.4M | 27.6M | 11.9M | -- |
| Accumulated Depreciation | -- | -- | -- | -16.5M | -- | -- |
| Net PPE | 9.1M | 9.8M | 10.4M | 11.2M | 11.9M | -- |
| Goodwill | -- | -- | -- | 0.00 | 5.9M | 5.9M |
| Goodwill And Other Intangible Assets | -- | -- | -- | 0.00 | 18.4M | 18.6M |
| Other Intangible Assets | -- | -- | -- | -- | 12.5M | 12.7M |
| Other Non Current Assets | 135,000 | 135,000 | 152,000 | 152,000 | 152,000 | -- |
| Total Non Current Assets | 9.3M | 10.0M | 10.6M | 11.3M | 30.5M | -- |
| Total Assets | 10.8M | 11.8M | 12.5M | 14.7M | 34.0M | -- |
| Current Debt | 6.6M | 4.7M | 4.4M | 9.1M | 4.7M | -- |
| Current Debt And Capital Lease Obligation | 7.0M | 5.1M | 4.8M | 9.5M | 5.2M | -- |
| Accounts Payable | -- | -- | -- | 4.5M | -- | -- |
| Payables | -- | -- | -- | 4.5M | -- | -- |
| Payables And Accrued Expenses | 8.7M | 8.6M | 7.5M | 7.9M | 9.1M | -- |
| Current Accrued Expenses | -- | -- | -- | 3.4M | -- | -- |
| Current Liabilities | 15.7M | 13.7M | 12.4M | 17.4M | 14.3M | -- |
| Long Term Debt | 6.1M | 5.7M | 5.5M | 371,000 | 428,000 | -- |
| Long Term Debt And Capital Lease Obligation | 8.1M | 7.9M | 7.6M | 2.6M | 2.8M | -- |
| Long Term Capital Lease Obligation | 2.0M | 2.1M | 2.1M | 2.3M | 2.4M | -- |
| Total Non Current Liabilities Net Minority Interest | 8.1M | 7.9M | 7.6M | 2.6M | 4.8M | -- |
| Total Liabilities Net Minority Interest | 23.8M | 21.6M | 20.0M | 20.0M | 19.1M | -- |
| Common Stock | 158.8M | 158.5M | 156.7M | 156.7M | 156.7M | -- |
| Capital Stock | 158.8M | 158.5M | 156.7M | 156.7M | 156.7M | -- |
| Additional Paid In Capital | 10.8M | 10.5M | 10.0M | 9.2M | 5.7M | -- |
| Retained Earnings | -186.0M | -182.4M | -178.0M | -174.0M | -152.3M | -- |
| Gains Losses Not Affecting Retained Earnings | 838,000 | 833,000 | 857,000 | 993,000 | 216,000 | -- |
| Other Equity Adjustments | 838,000 | 833,000 | 857,000 | 993,000 | 216,000 | -- |
| Common Stock Equity | -13.0M | -9.8M | -7.5M | -5.3M | 14.9M | -- |
| Stockholders Equity | -13.0M | -9.8M | -7.5M | -5.3M | 14.9M | -- |
| Total Equity Gross Minority Interest | -13.0M | -9.8M | -7.5M | -5.3M | 14.9M | -- |
| Total Capitalization | -6.9M | -4.0M | -2.0M | -5.0M | 15.3M | -- |
| Net Tangible Assets | -13.0M | -9.8M | -7.5M | -5.3M | -3.5M | -- |
| Tangible Book Value | -13.0M | -9.8M | -7.5M | -5.3M | -3.5M | -- |
| Working Capital | -14.1M | -11.9M | -10.5M | -14.0M | -10.8M | -- |
| Invested Capital | -242,000 | 690,000 | 2.4M | 4.1M | 20.0M | -- |
| Total Debt | 15.2M | 13.0M | 12.4M | 12.2M | 7.9M | -- |
| Net Debt | 12.4M | 9.9M | 9.2M | 7.6M | 4.8M | -- |
| Share Issued | 78.1M | 77.6M | 74.4M | 74.4M | 74.4M | -- |
| Ordinary Shares Number | 78.1M | 77.6M | 74.4M | 74.4M | 74.4M | -- |
| Buildings And Improvements | -- | -- | -- | 2.7M | -- | -- |
| Capital Lease Obligations | 2.4M | 2.5M | 2.6M | 2.7M | 2.8M | -- |
| Construction In Progress | -- | -- | -- | 705,000 | -- | -- |
| Current Capital Lease Obligation | 378,000 | 394,000 | 411,000 | 406,000 | 427,000 | -- |
| Current Notes Payable | 4.5M | 4.3M | 4.1M | 3.7M | 4.1M | -- |
| Finished Goods | -- | -- | -- | 281,000 | -- | -- |
| Land And Improvements | -- | -- | -- | 881,000 | -- | -- |
| Leases | -- | -- | -- | 10.7M | -- | -- |
| Line Of Credit | 336,000 | 186,000 | 84,000 | 81,000 | 181,000 | -- |
| Machinery Furniture Equipment | -- | -- | -- | 1.2M | -- | -- |
| Non Current Deferred Liabilities | -- | -- | -- | 0.00 | 2.0M | 2.1M |
| Non Current Deferred Taxes Liabilities | -- | -- | -- | 0.00 | 2.0M | 2.1M |
| Other Current Borrowings | 1.8M | 272,000 | 272,000 | 5.3M | 446,000 | -- |
| Other Equity Interest | 2.6M | 2.8M | 2.9M | 1.7M | 4.5M | -- |
| Other Inventories | -- | -- | -- | 349,000 | -- | -- |
| Other Properties | 9.1M | 9.8M | 10.4M | 11.5M | 11.9M | -- |
| Other Receivables | -- | -- | -- | 1,000 | -- | -- |
| Properties | -- | -- | -- | 0.00 | -- | -- |
| Raw Materials | -- | -- | -- | 0.00 | -- | -- |
| Taxes Receivable | -- | -- | -- | 313,000 | -- | -- |
| Work In Process | -- | -- | -- | 0.00 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.5M | -2.0M | -2.8M | -5.3M | -1.5M | -- |
| Cash Flow From Continuing Operating Activities | -2.5M | -2.0M | -2.8M | -5.3M | -1.5M | -- |
| Depreciation And Amortization | 723,000 | 676,000 | 694,000 | 792,000 | 721,000 | -- |
| Depreciation Amortization Depletion | 723,000 | 676,000 | 694,000 | 792,000 | 721,000 | -- |
| Stock Based Compensation | 35,000 | 47,000 | 50,000 | 82,000 | 99,000 | -- |
| Deferred Tax | 0.00 | 0.00 | 0.00 | -2.0M | -17,000 | -- |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | -2.0M | -17,000 | -- |
| Change In Working Capital | -48,000 | 1.2M | -103,000 | -2.9M | 1.4M | -- |
| Changes In Account Receivables | -53,000 | -25,000 | 52,000 | 39,000 | 691,000 | -- |
| Change In Receivables | -53,000 | -25,000 | 52,000 | 39,000 | 691,000 | -- |
| Change In Inventory | 65,000 | 31,000 | 48,000 | 251,000 | 88,000 | -- |
| Change In Payables And Accrued Expense | -36,000 | 1.2M | -319,000 | -1.7M | 950,000 | -- |
| Change In Payable | -- | -- | -319,000 | -- | -- | -- |
| Change In Other Current Assets | -- | -- | -- | -- | 0.00 | 1.6M |
| Other Non Cash Items | 370,000 | 600,000 | 614,000 | 337,000 | 354,000 | -- |
| Capital Expenditure | -- | -- | -- | -1,000 | -11,000 | -- |
| Purchase Of PPE | -9,000 | 0.00 | 0.00 | -1,000 | -11,000 | -- |
| Net PPE Purchase And Sale | -9,000 | 25,000 | 0.00 | -1,000 | -11,000 | -- |
| Sale Of Business | -- | -- | -- | 0.00 | 0.00 | -- |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | -- | 0.00 | 1.6M |
| Investing Cash Flow | -9,000 | 25,000 | 0.00 | 1.9M | -11,000 | -- |
| Cash Flow From Continuing Investing Activities | -9,000 | 25,000 | 0.00 | 1.9M | -11,000 | -- |
| Issuance Of Debt | 1.6M | 100,000 | 1.8M | 5.0M | 300,000 | -- |
| Repayment Of Debt | -50,000 | -89,000 | -158,000 | -17,000 | -2.6M | -- |
| Net Issuance Payments Of Debt | 1.6M | 11,000 | 1.6M | 5.0M | -2.3M | -- |
| Issuance Of Capital Stock | 732,000 | -- | -- | 0.00 | 3.3M | -- |
| Net Common Stock Issuance | 732,000 | -- | -- | 0.00 | 3.3M | -- |
| Financing Cash Flow | 2.3M | 1.8M | 1.6M | 5.0M | 1.0M | -- |
| Cash Flow From Continuing Financing Activities | 2.3M | 1.8M | 1.6M | 5.0M | 1.0M | -- |
| Changes In Cash | -198,000 | -104,000 | -1.2M | 1.6M | -490,000 | -- |
| Beginning Cash Position | 559,000 | 663,000 | 1.9M | 346,000 | 836,000 | -- |
| End Cash Position | 361,000 | 559,000 | 663,000 | 1.9M | 346,000 | -- |
| Free Cash Flow | -2.5M | -2.0M | -2.8M | -5.3M | -1.5M | -- |
| Asset Impairment Charge | 18,000 | 1,000 | 9,000 | 20.3M | 2,000 | -- |
| Change In Account Payable | -- | -- | -319,000 | -- | -- | -- |
| Change In Prepaid Assets | -24,000 | 3,000 | 116,000 | 308,000 | -304,000 | -- |
| Common Stock Issuance | 732,000 | -- | -- | 0.00 | 3.3M | -- |
| Interest Paid Cfo | -- | -- | -- | -2,000 | -- | -- |
| Long Term Debt Issuance | -- | 0.00 | 1.8M | -700,000 | 700,000 | 0.00 |
| Long Term Debt Payments | -50,000 | -89,000 | -158,000 | 416,000 | -597,000 | -- |
| Net Business Purchase And Sale | -- | -- | -- | 0.00 | 0.00 | -- |
| Net Foreign Currency Exchange Gain Loss | 5,000 | -24,000 | -136,000 | -72,000 | 5,000 | -- |
| Net Income From Continuing Operations | -3.6M | -4.4M | -4.0M | -21.7M | -3.9M | -- |
| Net Long Term Debt Issuance | -1.8M | -89,000 | 1.6M | -284,000 | -597,000 | -- |
| Net Short Term Debt Issuance | 3.4M | -- | -- | 5.3M | -1.7M | 400,000 |
| Operating Gains Losses | 5,000 | -24,000 | -136,000 | -72,000 | 5,000 | -- |
| Sale Of PPE | 0.00 | -- | -- | -- | 0.00 | -- |
| Short Term Debt Issuance | 3.4M | -- | -- | 5.7M | 300,000 | 400,000 |
| Short Term Debt Payments | -- | -- | -- | -433,000 | -2.0M | -- |